Litcius/Paper detail

VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study

Man‐Fung Yuen, Young‐Suk Lim, Ki Tae Yoon, Tien-Huey Lim, Jeong Heo, Pisit Tangkijvanich, Won Young Tak, Vaidehi Thanawala, D. C. Cloutier, Shenghua Mao, Andre Arizpe, Andrea L. Cathcart, Sneha Gupta, Carey Hwang, Edward Gane

2024˜The œLancet. Gastroenterology & hepatology67 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePegylated interferonVirologyImmunologyChronic hepatitisVirusRibavirinHepatitis B Virus StudiesHepatitis C virus researchRNA Interference and Gene Delivery
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study | Litcius